Mumps outbreaks, especially in adolescents and young adults, have been reported in the Czech Republic. The aim of the presented study was to determine the seroprevalence of specific IgG antibodies against mumps in the adult population of the Czech Republic. The study was designed as a multicenter serological survey of adults aged 18 years and over. Specific IgG antibodies against mumps were detected in blood samples using an enzyme-linked immunosorbent assay (ELISA). A total of 1,911 serum samples were examined. The overall seropositivity reached 55.3%. In individual age groups, the highest seropositivity 63% (63.5-65.2%) was recorded in adults aged 40 years and over; the lowest seropositivity was found in adults aged 18-29 years (27.4%). The difference in seropositivity rate between the 18-29 years age group and the 40 years and over age groups was statistically significant (p < 0.001). Only the 18-29 years age group included both vaccinated and unvaccinated (born in the pre-vaccine era) individuals. In vaccinated individuals, seropositivity was reported in only 19.1% of persons; in unvaccinated individuals, seropositivity reached 48.2%. Our results demonstrate the long-term persistence of antibodies following natural infection and the decrease in seropositivity that occurs after vaccination over time. This immunity waning may account for the higher susceptibility of adolescents and young adults to mumps. Therefore, the current vaccination program in the Czech Republic could be considered as less effective. It will be modified with the shifting of the second dose of vaccine from two years of age to the preschool age.

b Department of Rehabilitation University Hospital Hradec Kralove Czech Republic

c Military Health Institute Ceske Budejovice Czech Republic

Department of Epidemiology Faculty of Military Health Sciences University of Defence Hradec Kralove Czech Republic

Military Health Institute Brno Czech Republic

Zobrazit více v PubMed

World health Organization Global Immunization Data. July 2014. Available from: http://www.who.int/immunization/monitoring_surveillance/global_immunization_data.pdf?ua=1.

van Loon FP Holmes SJ, Sirotkin BI, Williams WW, Cochi SL, Hadler SC, Lindegren ML. Mumps surveillance – United States, 1988–1993. MMWR CDC Surveill Summ. 1995;44(3):1–14. PubMed

Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA. 2000;284(20):2643–7. doi:10.1001/jama.284.20.2643. PubMed DOI

Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77(1):3–14. PubMed PMC

Organization World Health. Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;87(22):217–24. PubMed

Dlhy J. Administrative estimate of vaccination coverage in the Czech Republic by December 31, 2010. Zpravy CEM (SZU, Praha), 2012;21(3):92–97.

Boxall N, Kubinyiova M, Prikazsky V, Benes C, Castkova J. An increase in the number of mumps cases in the Czech Republic, 2005–2006. Euro Surveill. 2008;13(16):pii = 18842. PubMed

Trmal J, Koci J, Simunkova L, Storkanova O, Trmalova Z. Mumps outbreak in the Usti administrative region. Zpravy CEM (SZU, Praha). 2011;20(6):219–23.

Lexova P, Limberkova R, Castkova J, Kyncl J. Increased incidence of mumps in the Czech Republic in the years 2011 and 2012. Acta Virol. 2013;57(3):347–51. PubMed

Stepanova V, Pliskova L, Kosina P, Splino M, Forstl M, Bolehovska R, Dlhy J, Chrzova M. Mumps – a reemerging infection? The current incidence of mumps in the East Bohemian region in the Czech Republic. Epidemiol Mikrobiol Imunol. 2006;55(4):127–35. PubMed

Institute of Health Information and Statistics of the Czech Republic. Infectious diseases 2012, UZIS CR 2013 Available from: http://www.uzis.cz/publikace/infekcni-nemoci-2012.

Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, et al.. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580–9. doi:10.1056/NEJMoa0706589. PubMed DOI

Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine. 2009;27(44):6186–95. doi:10.1016/j.vaccine.2009.06.109. PubMed DOI

Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12–7. doi:10.3201/eid1301.060649. PubMed DOI PMC

Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, de Melker HE, Hahne SJ. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine. 2010;28(17):2932–6. doi:10.1016/j.vaccine.2010.02.020. PubMed DOI

Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371(9616):932–44. doi:10.1016/S0140-6736(08)60419-5. PubMed DOI

Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An Assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014–20. doi:10.1503/cmaj.101371. PubMed DOI PMC

Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, Kikuta H, Togashi T. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol. 1998;5(6):799–803. PubMed PMC

Wiedermann U, Garner-Spitzer E, Wagner A. Primary vaccine failure to routine vaccines: Why and what to do? Hum Vaccin Immunother. 2016;12(1):239–43. doi:10.1080/21645515.2015.1093263. PubMed DOI PMC

Fine P, Eames K, Heymann DL. „Herd immunity“: A rough guide. Clin Infect Dis. 2011;52(7):911–6. doi:10.1093/cid/cir007. PubMed DOI

Fine PE. Herd immunity: History, theory, practise. Epidemiol Rev. 1993;15:265–302. doi:10.1093/oxfordjournals.epirev.a036121. PubMed DOI

McLean HQ, Hickman CJ, Seward JF. The Immunological Basis for Immunization Series. Module 16: Mumps. Available from: http://apps.who.int/iris/bitstream/10665/97885/1/9789241500661_eng.pdf.

Pipkin PA, Afzal MA, Heath AB, PDl Minor. Assay of humoral immunity to mumps virus. J Virol Methods. 1999;79(2):219–25. doi:10.1016/S0166-0934(99)00019-1. PubMed DOI

Stepanova V, Fajfr M, Pliskova L. Mumps – reemerging infection. Vakcinology. 2014;8(1):31.

Poethko-Müller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One. 2012;7(8):e42867. doi:10.1371/journal.pone.0042867. PubMed DOI PMC

Allwinn R, Zeidler B, Steinhagen K, Rohwäder E, Wicker S, Rabenau HF, Doerr HW. Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity? Eur J Clin Microbiol Infect Dis. 2011;30(10):1223–8. doi:10.1007/s10096-011-1216-z. PubMed DOI

Mrazova M, Smelhausova M, Sestakova Z. Serological Survey in the Czech Republic, 2001 – Mumps. Zpravy CEM (SZU, Praha). 2003;12(Suppl.1):44–8. PubMed

Mrazova M, Smelhausova M, Sestakova Z, Svandova E, Benes C. The 2001 serological survey in the Czech Republic – mumps. Cent Eur J Public Health. 2003;11 Suppl:S50–3. PubMed

Vygen S, Fischer A, Meurice L, Mounchetrou Njoya I, Gregoris M, Ndiaye B, Ghenassia A, Poujol I, Stahl JP, Antona D, et al.. Waning immunity against mumps in vaccinated young adults, France 2013. Eurosurveillance. 2016;21(10):pii = 30156. doi:10.2807/1560-7917.ES.2016.21.10.30156. PubMed DOI

Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine. 2004;22(21–22):2713–6. doi:10.1016/j.vaccine.2004.02.001. PubMed DOI

Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197(7):950–6. doi:10.1086/528993. PubMed DOI

Braeye T, Linina I, De Roy R Hutse V, Wauters M, Cox P, Mak R. Mumps increase in Flanders, Belgium, 2012–2013: Results form temporary mandatoruìy notification and a cohort study among university students. Vaccine. 2014;32(35):4393–8. doi:10.1016/j.vaccine.2014.06.069. PubMed DOI

Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol. 2012;86(1):615–20. doi:10.1128/JVI.06125-11. PubMed DOI PMC

Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198(4):508–15. doi:10.1086/590115. PubMed DOI

Orlikova H, Maly M, Lexova P, Sebestova H, Limberkova R, Jurzykowska L, Kyncl J. Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012. BMC Public Health. 2016;16:293. doi:10.1186/s12889-016-2958-4. PubMed DOI PMC

Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are two doses enough? Epidemiol Infect. 2012;140(3):439–46. doi:10.1017/S095026881100063X. PubMed DOI

Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, et al.. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis. 2008;197(12):1662–8. doi:10.1086/588197. PubMed DOI PMC

Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Zhang C, Ngo L, Rubin S. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis. 2014;1(3):ofu094. doi:10.1093/ofid/ofu094. PubMed DOI PMC

Huerta M, Davidovitch N, Aboudy Y, Ankol OE, Balicer RD, Zarka S, Grotto I. Declining population immunity to mumps among Israeli military recruits. Vaccine. 2006;24(37–39):6300–3. doi:10.1016/j.vaccine.2006.05.072. PubMed DOI

Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, et al.. Seroepidemiology of mumps in Europe (1996–2008): Why do outbreaks occur in highly vaccinated populations? Epidemiol Infect. 2013;141(3):651–6. doi:10.1017/S0950268812001136. PubMed DOI PMC

Monitoring the Effect of Vaccination on Mumps Cases Complications in the Czech Republic - Surveillance Data 2013-2022